Scope Fluidics S.A. (WSE:SCP)
Poland · Delayed Price · Currency is PLN 151.40
+17.00 (12.65%)
Oct 26, 2026, 5:02 PM CET
Scope Fluidics Revenue
Scope Fluidics had revenue of 32.00K PLN in the quarter ending June 30, 2026, with 39.13% growth. This brings the company's total for the last twelve months to 718.00K, up 503.36% year-over-year. In the year 2024, Scope Fluidics had annual revenue of 131.00K, down -74.61%. That makes Scope Fluidics the 48,098th largest company in the world by revenue and 611th in Poland.
Revenue (ttm)
718.00K
Revenue Growth
+503.36%
P/S Ratio
n/a
Revenue / Employee
-2.95K
Employees
175
Market Cap
479.68M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.00K | -385.00K | -74.61% |
| Dec 31, 2023 | 516.00K | 112.00K | 27.72% |
| Dec 31, 2022 | 404.00K | - | - |
| Dec 31, 2021 | 0 | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 1.80K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 183.23K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 14.14B |
| Diagnostyka | 2.58B |
| Synektik Spólka Akcyjna | 932.97M |
| Voxel | 640.61M |
| Mercator Medical | 620.68M |
| Selvita | 349.00M |
| Ryvu Therapeutics | 83.94M |
| Captor Therapeutics Spolka Akcyjna | 2.01M |